Research progress of lung organoids in infectious respiratory diseases
European Journal of Pharmacology · 2025
DOI: 10.1016/j.ejphar.2025.178201 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Pharmacology, 2025. Verfasst von Jun Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China. Hauptthemen laut MEDLINE: Organoids, Lung. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 110 Literaturangaben. Gefördert von: National Key Research and Development Program of China Stem Cell and Translational Research, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Infectious respiratory diseases are common epidemics that often exhibit phased outbreaks, increasing the healthcare burden. Past research models for these diseases were relatively simplistic, but the emergence of organoids has transformed this landscape. Organoids, three-dimensional in vitro tissue analogs that recapitulate specific spatial organ structures derived from stem cell culture, have advanced significantly over the decade since their inception. Compared to conventional animal models, organoids circumvent interspecies variations, enabling a more precise representation of human physiological and pathological traits. Relative to two-dimensional cell cultures, organoids exhibit enhanced complexity, incorporating diverse cell types and maintaining stable genomes, which facilitates a more faithful simulation of cellular interactions within the extracellular microenvironment. Consequently, as a three-dimensional in vitro model, lung organoids are pivotal for investigating lung organ development, infectious disease pathogenesis, and drug screening. Although SARS-CoV-2 is receding from the spotlight, advancing lung organoid development for addressing infectious respiratory diseases like influenza remains a priority. This review demonstrated the differentiation culture process of lung organoids and outlined advancements in utilizing organoids to elucidate pathogenic infection mechanisms, reveal virus-host interactions and screen therapeutic drugs over the past seven years. Additionally, we have summarized the advances in lung organoid model technologies and outlined their developmental directions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
- Center for Drug Safety Evaluation and Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, China; National Clinical Research Center for Infectious Diseases, China; Collaborative Innovation Center for Diagnosis and Treatment of Infectious…
- Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, 310015, China. Electronic address: kdyang@zjsru.edu.cn.
- Tiansure Pharmaceutical Co., Ltd, Hangzhou, 311051, China.
- Center for Drug Safety Evaluation and Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China; Nanhu Brain-computer Interface Institute, Hangzhou, 311100, China; Innovation Institute f…
Förderung
- National Key Research and Development Program of China Stem Cell and Translational Research
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Li, J., Yang, W., Liu, X., Yang, K., Zhou, J., & Yang, X. (2025). Research progress of lung organoids in infectious respiratory diseases. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.178201
Vancouver
Li J, Yang W, Liu X, Yang K, Zhou J, Yang X. Research progress of lung organoids in infectious respiratory diseases. European Journal of Pharmacology. 2025. doi:10.1016/j.ejphar.2025.178201
BibTeX
@article{Li2025,
author = {Li, Jun and Yang, Wendong and Liu, Xiaoli and Yang, Keda and Zhou, Jialin and Yang, Xiaochun},
title = {Research progress of lung organoids in infectious respiratory diseases},
journal = {European Journal of Pharmacology},
year = {2025},
doi = {10.1016/j.ejphar.2025.178201}
}
EUVIMED